We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Product Name glucose-LNP@PTX, glucose-modified liposome loaded with paclitaxel
Catalog Number R-ZHIGF12
Alias Glucose-lipid nanoparticle-paclitaxel complex
Appearance solid or liquid
Molecular Formula N/A
Solubility Soluble in organic solvents
Storage -20°C, protected from light
Purity 95%+
Shelf Life 1 year
Shipping Condition low temperature transport
Application targeted drug delivery
Specification 10mg：Inquiry
25mg：Inquiry
50mg：Inquiry
Description Glucose-LNP@PTX is a drug delivery system in which glucose-modified lipid nanoparticles are loaded with paclitaxel (PTX). Lipid nanoparticles (LNP) are composed of lipid components such as phospholipids and cholesterol. They have good biocompatibility and degradability. They can simulate the structure of biological membranes, effectively protect the paclitaxel wrapped in them, and prevent the drug from being degraded or metabolized in advance before reaching the lesion. Glucose, as a targeting modification molecule, can specifically bind to the overexpressed glucose transporter on the surface of tumor cells, giving the system tumor targeting ability and enabling drug-loaded nanoparticles to be enriched in tumor tissues. Paclitaxel is a classic anticancer drug that exerts its anticancer effect by inhibiting microtubule depolymerization and disrupting the mitotic process of tumor cells. Glucose-LNP@PTX, which combines the three, can improve the water solubility, stability and targeting of paclitaxel, reduce the side effects of the drug on normal tissues, and shows broad application prospects in the field of tumor treatment.
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
Place the Order
FAQs
logo

Enter your email here to subscribe.

Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket